HY-100208-10mg
|
MedChemexpress LLC
|
HC-067047 [CAS 883031-03-6]
|
|
Cancer-programmed cell death
|
|
HY-100208-100mg
|
MedChemexpress LLC
|
HC-067047 [CAS 883031-03-6]
|
|
Cancer-programmed cell death
|
|
HY-100208-25mg
|
MedChemexpress LLC
|
HC-067047 [CAS 883031-03-6]
|
|
Cancer-programmed cell death
|
|
HY-100208-5mg
|
MedChemexpress LLC
|
HC-067047 [CAS 883031-03-6]
|
|
Cancer-programmed cell death
|
|
HY-100208-50mg
|
MedChemexpress LLC
|
HC-067047 [CAS 883031-03-6]
|
|
Cancer-programmed cell death
|
|
HY-10037-10mg
|
MedChemexpress LLC
|
Quiflapon [CAS 136668-42-3]
|
|
COVID-19-immunoregulation
|
|
HY-10037-100mg
|
MedChemexpress LLC
|
Quiflapon [CAS 136668-42-3]
|
|
COVID-19-immunoregulation
|
|
HY-10037-5mg
|
MedChemexpress LLC
|
Quiflapon [CAS 136668-42-3]
|
|
COVID-19-immunoregulation
|
|
HY-10037-50mg
|
MedChemexpress LLC
|
Quiflapon [CAS 136668-42-3]
|
|
COVID-19-immunoregulation
|
|
HY-100402-10mg
|
MedChemexpress LLC
|
CFMTI [CAS 864864-17-5]
|
|
Cancer-programmed cell death
|
|
HY-100402-100mg
|
MedChemexpress LLC
|
CFMTI [CAS 864864-17-5]
|
|
Cancer-programmed cell death
|
|
HY-100402-25mg
|
MedChemexpress LLC
|
CFMTI [CAS 864864-17-5]
|
|
Cancer-programmed cell death
|
|
HY-100402-5mg
|
MedChemexpress LLC
|
CFMTI [CAS 864864-17-5]
|
|
Cancer-programmed cell death
|
|
HY-100402-50mg
|
MedChemexpress LLC
|
CFMTI [CAS 864864-17-5]
|
|
Cancer-programmed cell death
|
|
HY-100403-10mg
|
MedChemexpress LLC
|
Ro 67-7476 [CAS 298690-60-5]
|
|
Cancer-programmed cell death
|
|
HY-100403-100mg
|
MedChemexpress LLC
|
Ro 67-7476 [CAS 298690-60-5]
|
|
Cancer-programmed cell death
|
|
HY-100403-2mg
|
MedChemexpress LLC
|
Ro 67-7476 [CAS 298690-60-5]
|
|
Cancer-programmed cell death
|
|
HY-100403-25mg
|
MedChemexpress LLC
|
Ro 67-7476 [CAS 298690-60-5]
|
|
Cancer-programmed cell death
|
|
HY-100403-5mg
|
MedChemexpress LLC
|
Ro 67-7476 [CAS 298690-60-5]
|
|
Cancer-programmed cell death
|
|
HY-100403-50mg
|
MedChemexpress LLC
|
Ro 67-7476 [CAS 298690-60-5]
|
|
Cancer-programmed cell death
|
|
HY-100418-10mg
|
MedChemexpress LLC
|
SKA-111 [CAS 1369170-24-0]
|
|
|
|
HY-100418-25mg
|
MedChemexpress LLC
|
SKA-111 [CAS 1369170-24-0]
|
|
|
|
HY-100418-5mg
|
MedChemexpress LLC
|
SKA-111 [CAS 1369170-24-0]
|
|
|
|
HY-100483-1mg
|
MedChemexpress LLC
|
A-804598 [CAS 1125758-85-1]
|
|
Cancer-programmed cell death
|
|
HY-100483-10mg
|
MedChemexpress LLC
|
A-804598 [CAS 1125758-85-1]
|
|
Cancer-programmed cell death
|
|